Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 24, 2015
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2015-02-21$28.50/sh−637$18,155→ 44,252 total - Tax Payment
Common Stock
2015-02-22$28.50/sh−429$12,227→ 43,823 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.